Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer-Reference-Cited by-同舟云学术

Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer

Published:2020-04 Issue:4 Volume:353 Page:1900340
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch. Pharm.

Author:

Abdel‐Mohsen Heba T.¹^ORCID,Abd El‐Meguid Eman A.¹,El Kerdawy Ahmed M.²³,Mahmoud Abeer E. E.⁴,Ali Mamdouh M.⁴

Affiliation:

1. Department of Chemistry of Natural and Microbial Products, Division of Pharmaceutical and Drug Industries ResearchNational Research Centre Cairo Egypt

2. Department of Pharmaceutical Chemistry, Faculty of PharmacyCairo University Cairo Egypt

3. Department of Pharmaceutical Chemistry, Faculty of PharmacyNew Giza University Cairo Egypt

4. Department of Biochemistry, Division of Genetic Engineering and BiotechnologyNational Research Centre Cairo Egypt

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.201900340

Reference75 articles.

1. Drug Resistance in Cancer: An Overview

2. Cell Signaling by Receptor Tyrosine Kinases

3. Protein Kinase Inhibitors Drug Discovery

4. Kinase Inhibitors in Cancer Therapy

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

2. Oxindole–benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation;BMC Chemistry;2024-09-13

3. Diphenyl urea‐benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents;Drug Development Research;2024-08-24

4. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23

5. Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study;Molecules;2024-07-04